Exosomal transfer of pro-pyroptotic miR-216a-5p exacerbates anthracycline cardiotoxicity through breast cancer-heart pathological crosstalk
Abstract Doxorubicin (DOX) is the most effective chemotherapeutic for breast cancer, but it is usually associated with severe cardiotoxicity. Further investigation to alleviate its side effects is essential. The present study investigated the mechanism of the cross-organ communication between tumors...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-05-01
|
| Series: | Signal Transduction and Targeted Therapy |
| Online Access: | https://doi.org/10.1038/s41392-025-02245-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849309820941762560 |
|---|---|
| author | Yan Ma Yongjun Wang Renzheng Chen Yabin Wang Yan Fang Cheng Qin Tianhu Wang Xiaoying Shen Tingwen Zhou Lei Tian Ting Sun Li Fan Xiaoning Wang Dong Han Feng Cao |
| author_facet | Yan Ma Yongjun Wang Renzheng Chen Yabin Wang Yan Fang Cheng Qin Tianhu Wang Xiaoying Shen Tingwen Zhou Lei Tian Ting Sun Li Fan Xiaoning Wang Dong Han Feng Cao |
| author_sort | Yan Ma |
| collection | DOAJ |
| description | Abstract Doxorubicin (DOX) is the most effective chemotherapeutic for breast cancer, but it is usually associated with severe cardiotoxicity. Further investigation to alleviate its side effects is essential. The present study investigated the mechanism of the cross-organ communication between tumors and the heart and potential intervention targets. Morphological bubble-like protrusions were observed in both adult murine ventricular cardiomyocytes (AMVCs) and human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) cocultured with breast cancer cells (BCCs), along with elevated expression of pyroptosis-related proteins. Exosomes (EXOs) from DOX-treated BCCs aggravated DOX-induced cardiotoxicity (DOXIC) in an orthotopic mouse model of breast cancer. Blocking miRNAs by knocking down Rab27a or inhibiting the release of EXOs in cancer tissue by Dicer enzyme knockout attenuated this additional injury effect. Exosomal miRNA sequencing revealed that miR-216a-5p is especially upregulated in EXOs from DOX-induced BCCs. Mechanistically, miR-216a-5p was upregulated by enhanced transcription mediated by DOX-induced AMP-dependent transcription factor 3 (ATF3) and packaged into EXOs by splicing factor 3b subunit 4 (SF3B4) in BCCs. Itchy E3 ubiquitin-protein ligase (ITCH) was identified as a novel downstream target mRNA of miR-216a-5p. ITCH negatively mediated thioredoxin-interacting protein (TXNIP) ubiquitination to activate the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome pathway, ultimately leading to cardiomyocyte pyroptosis. Our findings revealed novel cross-organ pathogenic communication between breast cancer and the heart through the exosomal miR-216a-5p-mediated ITCH/TXNIP/NLRP3 pathway, which drives cardiomyocyte pyroptosis. These findings suggest that targeting myocardial miR-216a-5p or blocking harmful EXOs from breast cancer is a potential therapeutic strategy for alleviating DOXIC. |
| format | Article |
| id | doaj-art-ce2060bd8d1e4b5b91f84c86c2dbfab9 |
| institution | Kabale University |
| issn | 2059-3635 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Signal Transduction and Targeted Therapy |
| spelling | doaj-art-ce2060bd8d1e4b5b91f84c86c2dbfab92025-08-20T03:53:57ZengNature Publishing GroupSignal Transduction and Targeted Therapy2059-36352025-05-0110112610.1038/s41392-025-02245-4Exosomal transfer of pro-pyroptotic miR-216a-5p exacerbates anthracycline cardiotoxicity through breast cancer-heart pathological crosstalkYan Ma0Yongjun Wang1Renzheng Chen2Yabin Wang3Yan Fang4Cheng Qin5Tianhu Wang6Xiaoying Shen7Tingwen Zhou8Lei Tian9Ting Sun10Li Fan11Xiaoning Wang12Dong Han13Feng Cao14Chinese Military Medical School, National Clinical Research Center for Geriatric Diseases, The Second Medical Center, Chinese PLA General HospitalDepartment of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyChinese Military Medical School, National Clinical Research Center for Geriatric Diseases, The Second Medical Center, Chinese PLA General HospitalChinese Military Medical School, National Clinical Research Center for Geriatric Diseases, The Second Medical Center, Chinese PLA General HospitalChinese Military Medical School, National Clinical Research Center for Geriatric Diseases, The Second Medical Center, Chinese PLA General HospitalChinese Military Medical School, National Clinical Research Center for Geriatric Diseases, The Second Medical Center, Chinese PLA General HospitalChinese Military Medical School, National Clinical Research Center for Geriatric Diseases, The Second Medical Center, Chinese PLA General HospitalChinese Military Medical School, National Clinical Research Center for Geriatric Diseases, The Second Medical Center, Chinese PLA General HospitalDepartment of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyChinese Military Medical School, National Clinical Research Center for Geriatric Diseases, The Second Medical Center, Chinese PLA General HospitalChinese Military Medical School, National Clinical Research Center for Geriatric Diseases, The Second Medical Center, Chinese PLA General HospitalChinese Military Medical School, National Clinical Research Center for Geriatric Diseases, The Second Medical Center, Chinese PLA General HospitalChinese Military Medical School, National Clinical Research Center for Geriatric Diseases, The Second Medical Center, Chinese PLA General HospitalChinese Military Medical School, National Clinical Research Center for Geriatric Diseases, The Second Medical Center, Chinese PLA General HospitalChinese Military Medical School, National Clinical Research Center for Geriatric Diseases, The Second Medical Center, Chinese PLA General HospitalAbstract Doxorubicin (DOX) is the most effective chemotherapeutic for breast cancer, but it is usually associated with severe cardiotoxicity. Further investigation to alleviate its side effects is essential. The present study investigated the mechanism of the cross-organ communication between tumors and the heart and potential intervention targets. Morphological bubble-like protrusions were observed in both adult murine ventricular cardiomyocytes (AMVCs) and human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) cocultured with breast cancer cells (BCCs), along with elevated expression of pyroptosis-related proteins. Exosomes (EXOs) from DOX-treated BCCs aggravated DOX-induced cardiotoxicity (DOXIC) in an orthotopic mouse model of breast cancer. Blocking miRNAs by knocking down Rab27a or inhibiting the release of EXOs in cancer tissue by Dicer enzyme knockout attenuated this additional injury effect. Exosomal miRNA sequencing revealed that miR-216a-5p is especially upregulated in EXOs from DOX-induced BCCs. Mechanistically, miR-216a-5p was upregulated by enhanced transcription mediated by DOX-induced AMP-dependent transcription factor 3 (ATF3) and packaged into EXOs by splicing factor 3b subunit 4 (SF3B4) in BCCs. Itchy E3 ubiquitin-protein ligase (ITCH) was identified as a novel downstream target mRNA of miR-216a-5p. ITCH negatively mediated thioredoxin-interacting protein (TXNIP) ubiquitination to activate the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome pathway, ultimately leading to cardiomyocyte pyroptosis. Our findings revealed novel cross-organ pathogenic communication between breast cancer and the heart through the exosomal miR-216a-5p-mediated ITCH/TXNIP/NLRP3 pathway, which drives cardiomyocyte pyroptosis. These findings suggest that targeting myocardial miR-216a-5p or blocking harmful EXOs from breast cancer is a potential therapeutic strategy for alleviating DOXIC.https://doi.org/10.1038/s41392-025-02245-4 |
| spellingShingle | Yan Ma Yongjun Wang Renzheng Chen Yabin Wang Yan Fang Cheng Qin Tianhu Wang Xiaoying Shen Tingwen Zhou Lei Tian Ting Sun Li Fan Xiaoning Wang Dong Han Feng Cao Exosomal transfer of pro-pyroptotic miR-216a-5p exacerbates anthracycline cardiotoxicity through breast cancer-heart pathological crosstalk Signal Transduction and Targeted Therapy |
| title | Exosomal transfer of pro-pyroptotic miR-216a-5p exacerbates anthracycline cardiotoxicity through breast cancer-heart pathological crosstalk |
| title_full | Exosomal transfer of pro-pyroptotic miR-216a-5p exacerbates anthracycline cardiotoxicity through breast cancer-heart pathological crosstalk |
| title_fullStr | Exosomal transfer of pro-pyroptotic miR-216a-5p exacerbates anthracycline cardiotoxicity through breast cancer-heart pathological crosstalk |
| title_full_unstemmed | Exosomal transfer of pro-pyroptotic miR-216a-5p exacerbates anthracycline cardiotoxicity through breast cancer-heart pathological crosstalk |
| title_short | Exosomal transfer of pro-pyroptotic miR-216a-5p exacerbates anthracycline cardiotoxicity through breast cancer-heart pathological crosstalk |
| title_sort | exosomal transfer of pro pyroptotic mir 216a 5p exacerbates anthracycline cardiotoxicity through breast cancer heart pathological crosstalk |
| url | https://doi.org/10.1038/s41392-025-02245-4 |
| work_keys_str_mv | AT yanma exosomaltransferofpropyroptoticmir216a5pexacerbatesanthracyclinecardiotoxicitythroughbreastcancerheartpathologicalcrosstalk AT yongjunwang exosomaltransferofpropyroptoticmir216a5pexacerbatesanthracyclinecardiotoxicitythroughbreastcancerheartpathologicalcrosstalk AT renzhengchen exosomaltransferofpropyroptoticmir216a5pexacerbatesanthracyclinecardiotoxicitythroughbreastcancerheartpathologicalcrosstalk AT yabinwang exosomaltransferofpropyroptoticmir216a5pexacerbatesanthracyclinecardiotoxicitythroughbreastcancerheartpathologicalcrosstalk AT yanfang exosomaltransferofpropyroptoticmir216a5pexacerbatesanthracyclinecardiotoxicitythroughbreastcancerheartpathologicalcrosstalk AT chengqin exosomaltransferofpropyroptoticmir216a5pexacerbatesanthracyclinecardiotoxicitythroughbreastcancerheartpathologicalcrosstalk AT tianhuwang exosomaltransferofpropyroptoticmir216a5pexacerbatesanthracyclinecardiotoxicitythroughbreastcancerheartpathologicalcrosstalk AT xiaoyingshen exosomaltransferofpropyroptoticmir216a5pexacerbatesanthracyclinecardiotoxicitythroughbreastcancerheartpathologicalcrosstalk AT tingwenzhou exosomaltransferofpropyroptoticmir216a5pexacerbatesanthracyclinecardiotoxicitythroughbreastcancerheartpathologicalcrosstalk AT leitian exosomaltransferofpropyroptoticmir216a5pexacerbatesanthracyclinecardiotoxicitythroughbreastcancerheartpathologicalcrosstalk AT tingsun exosomaltransferofpropyroptoticmir216a5pexacerbatesanthracyclinecardiotoxicitythroughbreastcancerheartpathologicalcrosstalk AT lifan exosomaltransferofpropyroptoticmir216a5pexacerbatesanthracyclinecardiotoxicitythroughbreastcancerheartpathologicalcrosstalk AT xiaoningwang exosomaltransferofpropyroptoticmir216a5pexacerbatesanthracyclinecardiotoxicitythroughbreastcancerheartpathologicalcrosstalk AT donghan exosomaltransferofpropyroptoticmir216a5pexacerbatesanthracyclinecardiotoxicitythroughbreastcancerheartpathologicalcrosstalk AT fengcao exosomaltransferofpropyroptoticmir216a5pexacerbatesanthracyclinecardiotoxicitythroughbreastcancerheartpathologicalcrosstalk |